Skip to Main Content

Author Details

Giulia Biancon
Yale School of Medicine
2016
18
9
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37312418Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine Protection.Small Methods2023
37742191ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m<sup>6</sup>A modification-mediated RNA stability control.Cell Rep2023
35303483Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies.Mol Cell2022
35765315Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies.Open Forum Infect Dis2022
36516754Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis.Cell Rep2022
36595959Deconvolution of in vivo protein-RNA contacts using fractionated eCLIP-seq.STAR Protoc2022
36109149Widespread association of the Argonaute protein AGO2 with meiotic chromatin suggests a distinct nuclear function in mammalian male reproduction.Genome Res2022
36093346Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity.bioRxiv2022
35273342In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2.Leukemia2022
34589432Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases.Front Oncol2021
33674488Combined liver-cytokine humanization comes to the rescue of circulating human red blood cells.Science2021
32126144Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma.Blood Adv2020
32497523m[6]A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development.Immunity2020
31400824From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?Blood Rev2019
31474759Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.Br J Cancer2019
29789651Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.Leukemia2018
30165206Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNA: A Pilot Study.J Mol Diagn2018
27013207Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.Exp Hematol2016
  • 1 - 18 of 18

Recommended Authors

National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 0
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2015
Number of shared co-authors 1
Washington University in St Louis
Career Start Year 2015
Number of shared co-authors 0
Zurich University Hospital
Career Start Year 2013
Number of shared co-authors 3
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 0
Center for Genomic Medicine, Rigshospitalet Copenhagen University Hospital
Career Start Year 2012
Number of shared co-authors 0
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2012
Number of shared co-authors 0
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 0
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 2
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 0
Simon Fraser University
Career Start Year 2005
Number of shared co-authors 1
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 2
Washington University
Career Start Year 2003
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 4
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 0
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 3
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 0
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 0
Stanford University
Career Start Year 1994
Number of shared co-authors 0

Collaborators

Smilow Cancer Center, Yale University School of Medicine
Co-authored papers 13
Yale Comprehensive Cancer Center, Yale University School of Medicine
Co-authored papers 8
Yale Cancer Center and Smilow Cancer Hospital, Yale University School of Medicine
Co-authored papers 3
Yale University
Co-authored papers 3
Institute of Pathogens and Vectors, Dali University
Co-authored papers 3
The Ohio State University Wexner Medical Center
Co-authored papers 2
Yale Cancer Center and Yale School of Medicine
Co-authored papers 2
Institute of Medicine, University of Tsukuba
Co-authored papers 2
Yale University
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Yale School of Medicine, Yale School of Public Health
Co-authored papers 2
Yale University
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Wellcome Sanger Institute
Co-authored papers 1
Yale University
Co-authored papers 1
Yale University
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 1
Co-authored papers 1
Yale University
Co-authored papers 1
Co-authored papers 1
Wellcome Sanger Institute
Co-authored papers 1
Biodesign Institute, Arizona State University
Co-authored papers 1
Wellcome Sanger Institute
Co-authored papers 1
University of North Carolina School of Medicine
Co-authored papers 1